American Century Companies’s Iovance Biotherapeutics IOVA Stock Holding History

American Century Companies's IOVA Position: Q2 2026 in Review

American Century Companies increased its Iovance Biotherapeutics (IOVA) stake by 92% in Q2 2026, buying an estimated $1.25M and bringing the position to 684,673 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2090.

American Century Companies first reported a position in IOVA in Q3 2019 and has held it in 28 quarters since. The position peaked at $16M in Q4 2020. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

• American Century Companies held 684,673 shares of Iovance Biotherapeutics worth $2.85M as of Q2 2026.
• American Century Companies bought 328,867 Iovance Biotherapeutics shares in Q2 2026, an estimated $1.25M.
• Iovance Biotherapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2090 holding.
• American Century Companies first reported a position in Iovance Biotherapeutics in Q3 2019 and has held it in 28 quarters since.
• American Century Companies's Iovance Biotherapeutics position peaked at $16M in Q4 2020.
• 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.